...
首页> 外文期刊>Current opinion in organ transplantation >Regenerative medicine and tissue engineering: contribution of stem cells in organ transplantation.
【24h】

Regenerative medicine and tissue engineering: contribution of stem cells in organ transplantation.

机译:再生医学和组织工程:干细胞在器官移植中的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Regenerative medicine is a rapidly evolving field that focuses on harnessing the infinite self-renewal capacity of stem cells and their ability to differentiate into various lineages under appropriate conditions, to provide effective treatment for a range of diseases. This involves the repair or regeneration of cells, tissue or organs to restore impaired function. Embryonic stem cells (ESCs), originally isolated from mice in 1981 and later from human embryos in 1998, have high self-renewal potential, a limitless capacity of proliferation and are pluripo-tent, that is they can differentiate into all three embryonic germ layers. These cells have tremendous potential in tissue engineering; however, their use is hampered by ethical, legal and scientific considerations. On the contrary, nonembryonic stem cells or adult stem cells are multipotent, that is they give rise to progenitors with more restricted lineage potential and can be derived from several sources including bone marrow, umbilical cord tissue, amniotic fluid, fat tissue, skin, retina and central nervous system.
机译:再生医学是一个快速发展的领域,致力于利用干细胞的无限自我更新能力及其在适当条件下分化为各种谱系的能力,以提供对多种疾病的有效治疗。这涉及细胞,组织或器官的修复或再生,以恢复受损的功能。胚胎干细胞(ESC)最初于1981年从小鼠中分离出来,后来于1998年从人类胚胎中分离出来,具有很高的自我更新潜力,无限的增殖能力和多能性,也就是说,它们可以分化为所有三个胚芽层。这些细胞在组织工程中具有巨大的潜力。但是,它们的使用受到伦理,法律和科学方面的考虑。相反,非胚性干细胞或成体干细胞是多能的,也就是说,它们会产生具有更有限谱系潜能的祖细胞,并且可以来源于多种来源,包括骨髓,脐带组织,羊水,脂肪组织,皮肤,视网膜和中枢神经系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号